Kilitch Drugs (India) Ltd - ESG Rating & Company Profile powered by AI
This assessment of Kilitch Drugs (India) Ltd incorporates information from across the internet as well as from available disclosures by Kilitch Drugs (India) Ltd. If you work at Kilitch Drugs (India) Ltd and you would like to use your ESG aseessment, please contact us. Complete ESG analysis of Kilitch Drugs (India) Ltd are reached by logging in.
Kilitch Drugs (India) Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.4; made up of an environmental score of 8.0, social score of 0.0 and governance score of 5.3.
4.4
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
868 | Trevena Inc | 4.5 | High |
868 | Urogen Pharma Ltd | 4.5 | High |
910 | Kilitch Drugs (India) Ltd | 4.4 | High |
910 | CanBas Co Ltd | 4.4 | High |
910 | CNS Pharmaceuticals Inc | 4.4 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Kilitch Drugs (India) Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Kilitch Drugs (India) Ltd disclose current and historical energy intensity?
Does Kilitch Drugs (India) Ltd report the average age of the workforce?
Does Kilitch Drugs (India) Ltd reference operational or capital allocation in relation to climate change?
Does Kilitch Drugs (India) Ltd disclose its ethnicity pay gap?
Does Kilitch Drugs (India) Ltd disclose cybersecurity risks?
Does Kilitch Drugs (India) Ltd offer flexible work?
Does Kilitch Drugs (India) Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Kilitch Drugs (India) Ltd disclose the number of employees in R&D functions?
Does Kilitch Drugs (India) Ltd conduct supply chain audits?
Does Kilitch Drugs (India) Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Kilitch Drugs (India) Ltd conduct 360 degree staff reviews?
Does Kilitch Drugs (India) Ltd disclose the individual responsible for D&I?
Does Kilitch Drugs (India) Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Kilitch Drugs (India) Ltd disclose current and / or historical scope 2 emissions?
Does Kilitch Drugs (India) Ltd disclose water use targets?
Does Kilitch Drugs (India) Ltd have careers partnerships with academic institutions?
Did Kilitch Drugs (India) Ltd have a product recall in the last two years?
Does Kilitch Drugs (India) Ltd disclose incidents of discrimination?
Does Kilitch Drugs (India) Ltd allow for Work Councils/Collective Agreements to be formed?
Has Kilitch Drugs (India) Ltd issued a profit warning in the past 24 months?
Does Kilitch Drugs (India) Ltd disclose parental leave metrics?
Does Kilitch Drugs (India) Ltd disclose climate scenario or pathway analysis?
Does Kilitch Drugs (India) Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Kilitch Drugs (India) Ltd disclose the pay ratio of women to men?
Does Kilitch Drugs (India) Ltd support suppliers with sustainability related research and development?
Does Kilitch Drugs (India) Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Kilitch Drugs (India) Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Kilitch Drugs (India) Ltd involved in embryonic stem cell research?
Does Kilitch Drugs (India) Ltd disclose GHG and Air Emissions intensity?
Does Kilitch Drugs (India) Ltd disclose its waste policy?
Does Kilitch Drugs (India) Ltd report according to TCFD requirements?
Does Kilitch Drugs (India) Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Kilitch Drugs (India) Ltd disclose energy use targets?
Does Kilitch Drugs (India) Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Kilitch Drugs (India) Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Kilitch Drugs (India) Ltd
These potential risks are based on the size, segment and geographies of the company.
Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products, including gastroenterology, anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, non-steroidal anti-inflammatory, oncology, ophthalmic, and other drugs, as well as vaccines and veterinary products in the form of ampoules, vials, and dry powder injectables. Its parenteral and nasal products also include iron supplements for the treatment of anemia; and metered nasal drops, as well as Klavmox and Onecef products. The company also provides a range of oral formulations, including tablets, capsules, dry syrup, gripe water, and oral powder and liquid in the antibiotic, anti-diabetics, cardiovascular, and other areas. In addition, it offers effervescent tablets and powders, such as ROIPAR, DUREGRA, ROIVIT, and PH-7; and various nutritional products, such as CELTINE. Further, the company provides C-Seal, a topical skin adhesive to hold closely approximated skin edges without marks of sutures and incisions. Additionally, it offers cosmetics and herbal products consisting of a range of oils, lotions, liquids, creams, and paste in skin, personal, and hair care categories, as well as herbal products used in sore throat and prostate problems; and as a supplement for diabetes, obesity, libido, and other conditions. The company also exports its products. Kilitch Drugs (India) Limited was founded in 1978 and is headquartered in Mumbai, India.